SCIER Author Services

今天，我们来看看这本SCI期刊：INTERNATIONAL IMMUNOPHARMACOLOGY。从现有的记录来看，AINTERNATIONAL IMMUNOPHARMACOLOGY 的2021年影响因子(JCR2020)是4.932，自引率5.72%。

期刊基本信息

关于此刊的具体情况，大家可以看看：

https://www.sciencedirect.com/journal/international-immunopharmacology

来自期刊官网

期刊接受范围

INTERNATIONAL IMMUNOPHARMACOLOGY 的收稿范围，期刊是如此介绍的(截取部分内容)，详情请阅读：

https://www.sciencedirect.com/journal/international-immunopharmacology/about/aims-and-scope

International Immunopharmacologyis the primary vehicle for the publication of original research papers pertinent to the overlapping areas ofimmunology,pharmacology,cytokine biology,immunotherapy,immunopathologyandimmunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

......

期刊接受时间

对于 INTERNATIONAL IMMUNOPHARMACOLOGY 的接受时间，我们看了几篇新近发表的：只需1-5个月就可以接受！

• Received 18 August 2021; Accepted 29 September 2021
• Received 16 June 2021; Accepted 23 August 2021
• Received 18 June 2021; Accepted 16 September 2021
• Received 1 April 2021; Accepted 6 May 2021
• Received 21 September 2020; Accepted 22 February 2021
•  

期刊年发文量

对于 INTERNATIONAL IMMUNOPHARMACOLOGY 的发文量，2018年发文490多篇，2019年发文670多篇，2020年发文970多篇，2021年发文1040多篇。

影响因子

即时影响因子计算发现，2022年3月24日，5.626分。按照常规期刊计算方法，以及往年经验，在2022年6月份公布的IF中，它或首超5分！期待6月份新IF的公布！

投稿网址及网页界面

想必大家对如何投稿，也很感兴趣，这里我们简单介绍一下投稿界面

https://www.editorialmanager.com/intimp/default1.aspx

如果还没有注册过账户，只需点击“Register Now”注册账户即可！

版权声明：本文转自“51选刊”，文章转载只为学术传播，不代表本号观点，无商业用途，版权归原作者所有，如涉及侵权问题，请联系我们，我们将及时修改或删除。